77 related articles for article (PubMed ID: 38502889)
1. Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events.
Ben Khaled N; Möller M; Jochheim LS; Leyh C; Ehmer U; Böttcher K; Pinter M; Balcar L; Scheiner B; Weich A; Leicht HB; Zarka V; Ye L; Schneider J; Piseddu I; Öcal O; Rau M; Sinner F; Venerito M; Gairing SJ; Förster F; Mayerle J; De Toni EN; Geier A; Reiter FP
JHEP Rep; 2024 Jun; 6(6):101065. PubMed ID: 38798717
[TBL] [Abstract][Full Text] [Related]
2. The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma.
Lee MMP; Chan LL; Chan SL
J Liver Cancer; 2023 Sep; 23(2):262-271. PubMed ID: 37589044
[TBL] [Abstract][Full Text] [Related]
3. Insights in Molecular Therapies for Hepatocellular Carcinoma.
Heumann P; Albert A; Gülow K; Tümen D; Müller M; Kandulski A
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791911
[TBL] [Abstract][Full Text] [Related]
4. Downstaging with Atezolizumab-Bevacizumab: A Case Series.
Kulkarni AV; P K; Menon B; Sekaran A; Rambhatl A; Iyengar S; Alla M; Venishetty S; Ramachandra SK; V PG; Sharma M; Rao PN; Reddy DN; Singal AG
J Liver Cancer; 2024 May; ():. PubMed ID: 38797993
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards.
Siegel RD; LeFebvre KB; Temin S; Evers A; Barbarotta L; Bowman RM; Chan A; Dougherty DW; Ganio M; Hunter B; Klein M; Miller TP; Mulvey TM; Ouzts A; Polovich M; Salazar-Abshire M; Stenstrup EZ; Sydenstricker CM; Tsai S; Oslen MM
JCO Oncol Pract; 2024 May; ():OP2400216. PubMed ID: 38776491
[TBL] [Abstract][Full Text] [Related]
6. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline.
Gordan JD; Kennedy EB; Abou-Alfa GK; Beg MS; Brower ST; Gade TP; Goff L; Gupta S; Guy J; Harris WP; Iyer R; Jaiyesimi I; Jhawer M; Karippot A; Kaseb AO; Kelley RK; Knox JJ; Kortmansky J; Leaf A; Remak WM; Shroff RT; Sohal DPS; Taddei TH; Venepalli NK; Wilson A; Zhu AX; Rose MG
J Clin Oncol; 2020 Dec; 38(36):4317-4345. PubMed ID: 33197225
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab.
Kikugawa C; Uchikawa S; Kawaoka T; Kinami T; Yano S; Amioka K; Naruto K; Ando Y; Yamaoka K; Tsuge M; Kosaka Y; Ohya K; Mori N; Takaki S; Tsuji K; Kouno H; Kohno H; Morio K; Moriya T; Nonaka M; Aisaka Y; Masaki K; Honda Y; Naeshiro N; Hiramatsu A; Aikata H; Oka S
Oncology; 2024; 102(3):239-251. PubMed ID: 37729889
[TBL] [Abstract][Full Text] [Related]
8. Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma: A Review.
Cappuyns S; Corbett V; Yarchoan M; Finn RS; Llovet JM
JAMA Oncol; 2024 Mar; 10(3):395-404. PubMed ID: 37535375
[TBL] [Abstract][Full Text] [Related]
9. Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment.
Chen CT; Feng YH; Yen CJ; Chen SC; Lin YT; Lu LC; Hsu CH; Cheng AL; Shao YY
Hepatol Int; 2022 Oct; 16(5):1199-1207. PubMed ID: 35986846
[TBL] [Abstract][Full Text] [Related]
10. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.
Gordan JD; Kennedy EB; Abou-Alfa GK; Beal E; Finn RS; Gade TP; Goff L; Gupta S; Guy J; Hoang HT; Iyer R; Jaiyesimi I; Jhawer M; Karippot A; Kaseb AO; Kelley RK; Kortmansky J; Leaf A; Remak WM; Sohal DPS; Taddei TH; Wilson Woods A; Yarchoan M; Rose MG
J Clin Oncol; 2024 May; 42(15):1830-1850. PubMed ID: 38502889
[TBL] [Abstract][Full Text] [Related]
11. First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination.
Tella SH; Kommalapati A; Mahipal A; Jin Z
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740326
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]